Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (21)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Palm, O.
Right arrow Articles by Gran, J. T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Palm, O.
Right arrow Articles by Gran, J. T.
Related Collections
Right arrow Spondylarthropathies
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2001; 40: 1256-1261
© 2001 British Society for Rheumatology

Original Papers

The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study)

Ø. Palm1,2,, B. Moum3, J. Jahnsen4 and J. T. Gran2

1 Department of Rheumatology, Østfold Central Hospital, N-1701 Sarpsborg,
2 Department of Rheumatology, Institute of Clinical Medicine, University of Tromsø, N-9038 Tromsø,
3 Department of Gastroenterology, Østfold Central Hospital, N-1603 Fredrikstad and
4 Department of Gastroenterology, Aker University Hospital, N-0514 Oslo, Norway

Objectives. To estimate the occurrence of peripheral arthritis (PA) 6 yr after diagnosis of inflammatory bowel disease (IBD).

Methods. In a population-based cohort of 654 patients with a definite diagnosis of IBD, 521 patients (80%) were clinically examined by a rheumatologist 6 yr after IBD diagnosis.

Results. PA related to IBD (PAIBD) was detected at examination in four patients (point prevalence 0.8%). If the patients’ own reports of PA were accepted, 12% of the cases had developed such manifestations. The striking difference may be explained by the nature of PAIBD exhibiting a short-lasting, self-limiting, non-destructive course and by possible differences in the validity of both methods of ascertainment.

Conclusion. Our results indicate that PAIBD occurs in a considerable number of IBD patients during the first years after diagnosis, but the point prevalence of PAIBD is low.

KEY WORDS: Arthritis, Crohn's disease, Epidemiology, Extra-intestinal manifestations, Incidence, Inflammatory bowel disease, Peripheral arthropathy, Prevalence, Ulcerative colitis.

Correspondence to: Ø. Palm.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
S. Z. Aydin, P. Atagunduz, M. Temel, M. Bicakcigil, D. Tasan, and H. Direskeneli
Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment
Rheumatology, February 1, 2008; 47(2): 142 - 144.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.